On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Xinyu Pharmaceutical Co.,Ltd.

24 YRS

Anhui, China

CNY 90 Million

333000 m²

500-1000 people

Main Products: Clindamycin Phosphate / Lincomycin Hydrochloride Monohydrate / Clindamycin Hydrochloride Monohydrate / Neomycin Sulfate / Moxidectin / Lincomycin Hydrochloride

Anhui, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

Clindamycin Hydrochloride Monohydrate / CAS 58207-19-5

OVERVIEW

Packaging

20 KG/Fibre Drum

Lead Time

14-30 days

Max Capacity

150 MT/Year

REQUEST A QUOTATION

Submit

Get Free Samples

Less than 1KG required

DESCRIPTION

Clindamycin Hydrochloride Monohydrate

Product Category:Pharmaceutical raw materials

Cas.NO:58207-19-5

Quality standard:ChP/USP/EP

Registered trademark:North of Anhui Province

Packaging:20kg/drum

Domestic and international registration:

China NMPA

CDE Registration no.: Y20190007894

Original drug approval number: SFDA approval numberH20103316

America FDA

DMF register

DMF No.: 32342

【Molecular formula】C₁₈H₃₃ClN₂O₅S·HCl

【Molecular weight】461.44

【Appearance】white crystalline powder.

【Antibacterial action and application】 this product is applicable to moderate and severe infections caused by Streptococcus, Staphylococcus and anaerobic bacteria (including Bacteroides fragilis, Clostridium perfringens, actinomycetes, etc.), such as aspiration pneumonia, empyema, lung abscess, osteomyelitis, abdominal infection, pelvic infection and sepsis. It can be used for injection, capsule, ointment, gel, liniment and other formulations. It is suitable for the following infectious diseases caused by Gram positive bacteria and anaerobic bacteria, such as tonsillitis, suppurative otitis media, acute and chronic bronchitis, pneumonia, skin and soft tissue infection, urinary tract infection, female pelvic and genital infection, oral infection, etc. Osteomyelitis and infection after gynecological surgery.

Typical Properties

this product is applicable to moderate and severe infections caused by Streptococcus, Staphylococcus and anaerobic bacteria (including Bacteroides fragilis, Clostridium perfringens, actinomycetes, etc.), such as aspiration pneumonia, empyema, lung abscess, osteomyelitis, abdominal infection, pelvic infection and sepsis. It can be used for injection, capsule, ointment, gel, liniment and other formulations. It is suitable for the following infectious diseases caused by Gram positive bacteria and anaerobic bacteria, such as tonsillitis, suppurative otitis media, acute and chronic bronchitis, pneumonia, skin and soft tissue infection, urinary tract infection, female pelvic and genital infection, oral infection, etc. Osteomyelitis and infection after gynecological surgery.

CAS No.

58207-19-5

Formula

C18H34Cl2N2O5S

Molecular Mass

461.44

Exact Mass

478.16700

PSA

136.79000

Logp

1.45600

IUPAC

(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrate;hydrochloride

SMILES

CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl.O.Cl

GET SAMPLE